Page last updated: 2024-10-23

bumetanide and Rett Syndrome

bumetanide has been researched along with Rett Syndrome in 2 studies

Rett Syndrome: An inherited neurological developmental disorder that is associated with X-LINKED INHERITANCE and may be lethal in utero to hemizygous males. The affected female is normal until the age of 6-25 months when progressive loss of voluntary control of hand movements and communication skills; ATAXIA; SEIZURES; autistic behavior; intermittent HYPERVENTILATION; and HYPERAMMONEMIA appear. (From Menkes, Textbook of Child Neurology, 5th ed, p199)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's2 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lozovaya, N1
Nardou, R1
Tyzio, R1
Chiesa, M1
Pons-Bennaceur, A1
Eftekhari, S1
Bui, TT1
Billon-Grand, M1
Rasero, J1
Bonifazi, P1
Guimond, D1
Gaiarsa, JL1
Ferrari, DC1
Ben-Ari, Y1
Bou Khalil, R1

Other Studies

2 other studies available for bumetanide and Rett Syndrome

ArticleYear
Early alterations in a mouse model of Rett syndrome: the GABA developmental shift is abolished at birth.
    Scientific reports, 2019, 06-25, Volume: 9, Issue:1

    Topics: Animals; Bumetanide; gamma-Aminobutyric Acid; Methyl-CpG-Binding Protein 2; Mice; Mice, Inbred C57BL

2019
Is insulin growth factor-1 the future for treating autism spectrum disorder and/or schizophrenia?
    Medical hypotheses, 2017, Volume: 99

    Topics: Animals; Autism Spectrum Disorder; Brain; Bumetanide; Child; Child, Preschool; Chlorides; Endocannab

2017